Pancreatin: Clinical Trials

7 trials of Pancreatin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 3 Phase 4, 2 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Recruiting 1, Unknown 1
Not applicable2Not yet recruiting 1, Unknown 1
Phase 32Completed 2

Follow this drug Literature Review of Pancreatin trials Research Report on Pancreatin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery
High-dose group: Oryz-Aspergillus Enzyme and Pancreatin Tablet, Low-dose group: Oryz-Aspergillus Enzyme And Pancreatin Tablet - Pancreatic Exocrine Insufficiency, Adul
Not applicableNot yet recruitingTianjin Medical University Cancer Institute and Hospital1502026-09-182026-08-07
Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes
Pancreatin, Placebo - Type 2 Diabetes (T2DM)
Phase 4RecruitingSilesian Centre for Heart Diseases1002026-08-012026-10-01
A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition
Oryz-Aspergillus Enzyme and Pancreatin Tablet, Placebo - Cirrhosis
Not applicableUnknownShenzhen Kangzhe Pharmaceutical Co., Ltd.1322019-08-302019-08-15
The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps
Combizym, Bifidobacteri, Combizym + Bifidobacteri - Combizym, Bifidobacteri
Phase 4UnknownRenJi Hospital2002013-06-012020-03-05
Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency
Pancreatin - Pancreatic Exocrine Insufficiency
Phase 3CompletedAbbott Products402012-06-012014-07-15
Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis
Pancreatin, Placebo - Pancreatic Insufficiency
Phase 3CompletedAbbott Products622008-06-012011-08-18
Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy
Pancreatin, Placebo - Gastrectomy
Phase 4CompletedSolvay Pharmaceuticals402003-12-012008-03-31

Conditions studied

Exocrine Pancreatic Insufficiency (3)  ·  Colonic Polyps (1)  ·  Cystic Fibrosis (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fibrosis (1)

Sponsors

Abbott Products (2)  ·  RenJi Hospital (1)  ·  Shenzhen Kangzhe Pharmaceutical Co., Ltd. (1)  ·  Silesian Centre for Heart Diseases (1)  ·  Solvay Pharmaceuticals (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)

Countries

China (2)  ·  Denmark (1)  ·  Finland (1)  ·  India (1)  ·  Norway (1)  ·  Poland (1)  ·  Russia (1)  ·  Sweden (1)

Top investigators

Guenter Krause, MD (1)  ·  Shengliang Chen (1)  ·  Suntje Sander-Struckmeier, PhD (1)

Results publications

PMID 25066363